Back
Greenpro Capital 10K Form
Buy
52
GRNQ
Greenpro Capital
Last Price:
1.06
Seasonality Move:
16.45%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-08-14 | 10Q | GRNQ/Greenpro Capital Quarterly |
2020-05-14 | 10Q | GRNQ/Greenpro Capital Quarterly |
2020-03-30 | 10K | GRNQ/Greenpro Capital Annual |
2019-11-06 | 10Q | GRNQ/Greenpro Capital Quarterly |
2019-08-08 | 10Q | GRNQ/Greenpro Capital Quarterly |
2019-05-10 | 10Q | GRNQ/Greenpro Capital Quarterly |
Receive GRNQ News And Ratings
See the #1 stock for the next 7 days that we like better than GRNQ
GRNQ Financial Statistics
Sales & Book Value
Annual Sales: | $3.48M |
---|---|
Cash Flow: | $-151.7K |
Price / Cash Flow: | 0 |
Annual Sales: | $0.64 |
Price / Book: | 1.67 |
Profitability
EPS (TTM): | -0.86000 |
---|---|
Net Income (TTM): | $-6.67M |
Gross Margin: | $2.91M |
Return on Equity: | -97.87% |
Return on Assets: | -74.95% |
Greenpro Capital Earnings Forecast
Key Greenpro Capital Financial Ratios
- The Gross Profit Margin over the past 10 years for GRNQ is 83.56%.
- The Selling, General & Administrative Expenses for GRNQ have been equal to 126.79% of Gross Profit Margin.
- The Interest Expense is 0.07% of Operating Income.
- The Net Earning history of GRNQ is 30.87% of Total Revenues.
- Per Share Earnings over the last 10 years have been positive in 4 years.
Greenpro Capital Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Capital Markets |
Sector: | Financials |
Current Symbol: | GRNQ |
CUSIP: | 39540F |
Website: | greenprocapital.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.35 |
Quick Ratio: | 1.05 |
Price-to-Earnings
Trailing P/E Ratio: | 7.61 |
---|---|
Forward P/E Ratio: | 0 |
GRNQ Technical Analysis vs Fundamental Analysis
Buy
52
Greenpro Capital (GRNQ)
is a Buy
Is Greenpro Capital a Buy or a Sell?
-
Greenpro Capital stock is rated a Buy
The current Greenpro Capital [GRNQ] share price is $1.07. The Score for GRNQ is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.